UK-Based Oxford Nanopore Technologies Raises £40 Million in New Funding

Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £40 million in new funding through a private placement of ordinary shares. The investment was received from new and existing investors in the US, UK and mainland Europe. New investors include Odey Asset Management.

Funds will be used to further develop the Company's commercial and manufacturing infrastructure, continue innovative research and development in nanopore sensing and for various corporate objectives including the building and defence of the Company's broad intellectual property portfolio.
This transaction brings the total funds raised by Oxford Nanopore since its foundation in 2005 to £145 million.

Note: The placement of ordinary shares in the Company under this fundraising does not constitute an offer of the Company’s shares to the public. No shares in the Company will be offered or sold to any person except in circumstances which have not resulted and will not result in an offer to the public.

Zoe McDougall, Communications, Oxford Nanopore
[email protected]
+44 (0) 845 034 7900 x2013

About Oxford Nanopore
Oxford Nanopore Technologies® is developing a new generation of nanopore-based electronic systems for analysis of single molecules including DNA, RNA and proteins. The GridION™ system and miniaturised MinION™ device are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows and direct analysis of the molecule of interest. The devices may be used use in scientific research, personalised medicine, crop science, security & defence and environmental applications.
Oxford Nanopore has licensed or owns more than 350 patents and patent applications that relate to many aspects of nanopore sensing from protein nanopores to solid state nanopores and for the analysis of DNA, proteins and other molecules. This includes the use of functionalised solid-state nanopores for molecular characterisation, methods of fabricating solid-state nanopores and modifications of solid-state nanopores to adjust sensitivity or other parameters.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Nanopore Technologies Ltd. (2019, February 11). UK-Based Oxford Nanopore Technologies Raises £40 Million in New Funding. AZoNano. Retrieved on May 29, 2024 from

  • MLA

    Oxford Nanopore Technologies Ltd. "UK-Based Oxford Nanopore Technologies Raises £40 Million in New Funding". AZoNano. 29 May 2024. <>.

  • Chicago

    Oxford Nanopore Technologies Ltd. "UK-Based Oxford Nanopore Technologies Raises £40 Million in New Funding". AZoNano. (accessed May 29, 2024).

  • Harvard

    Oxford Nanopore Technologies Ltd. 2019. UK-Based Oxford Nanopore Technologies Raises £40 Million in New Funding. AZoNano, viewed 29 May 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.